Is Nanobiotix SA NBTX stock halal to invest in?

Yes, as of August 2026, Nanobiotix SA stock (NBTX) is classified as a Shariah compliant stock. This verdict follows the screening methodology of AAOIFI (the Accounting and Auditing Organization for Islamic Financial Institutions), whose Shariah Standard No. 21 is the leading global benchmark for screening halal stocks. Nanobiotix SA currently passes all four AAOIFI financial screens: non-permissible income remains below 5% of total revenue, interest-bearing investments and interest-bearing debt each remain below 30% of market capitalisation, and the company has no impermissible preference share structure. The stock's current purification factor is 98.92%. Compliance is reassessed every month as updated screening data arrives, and a stock's status can change when new financial reports are released. You can always check the current status of Nanobiotix SA and explore other Shariah compliant stocks in the Tabadulat app.

How often is Nanobiotix SA NBTX reviewed for Shariah compliance?

Tabadulat reviews Nanobiotix SA NBTX for Shariah compliance every month. Each review applies the AAOIFI Shariah Standard No. 21 methodology, screening the company's business activities, non-permissible income, interest-bearing investments, interest-bearing debt, and preference shares, against the company's latest available financial data. The process operates under the direct supervision of Tabadulat's dedicated Shariah Supervisory Board of Islamic finance scholars. Because compliance depends on financial ratios that move with market capitalisation and reported results, a stock's status can change from one review to the next. Monthly screening ensures the status shown for Nanobiotix SA reflects current financial data rather than an outdated assessment, and Tabadulat app users are notified if a holding in their portfolio becomes non-compliant.

Does Nanobiotix SA NBTX pass the AAOIFI Non Permissible Income criteria?

Yes, as of August 2026, Nanobiotix SA stock (NBTX) passes the AAOIFI non-permissible income screen. Under AAOIFI Shariah Standard No. 21, income from impermissible sources (such as interest or riba, conventional financial services, alcohol, gambling, or tobacco) must remain below 5% of a company's total revenue. Nanobiotix SA's income from non-permissible sources is currently within this 5% threshold. Even permissible levels of incidental impure income should still be purified: investors donate the corresponding share of dividends to charity, as reflected in the stock's purification factor. This screen is reassessed monthly using the company's latest financial disclosures.

Does Nanobiotix SA NBTX pass the AAOIFI Interest Bearing Investments criteria?

Yes, as of August 2026, Nanobiotix SA stock (NBTX) passes the AAOIFI interest-bearing investments screen. Under AAOIFI Shariah Standard No. 21, the cash a company places in interest-earning instruments (such as conventional deposits, bonds, treasury bills and money-market funds) must remain below 30% of its market capitalisation. This limit ensures shareholders are not materially profiting from riba (interest). Nanobiotix SA's interest-bearing investments are currently within the 30% threshold. Because the ratio is measured against market capitalisation, it can move with the share price as well as the balance sheet, which is why Tabadulat rescreens the stock every month.

Does Nanobiotix SA NBTX pass the AAOIFI Interest Bearing Debt criteria?

Yes, as of August 2026, Nanobiotix SA stock (NBTX) passes the AAOIFI interest-bearing debt screen. Under AAOIFI Shariah Standard No. 21, a company's borrowings that accrue interest (conventional bank loans, bonds and similar riba-based financing) must remain below 30% of its market capitalisation. This cap limits shareholders' exposure to interest-based leverage. Nanobiotix SA's interest-bearing debt is currently within the 30% threshold. Because market capitalisation changes daily, a company's debt ratio can drift toward or away from the limit even without new borrowing, which is why this screen is reassessed every month.

What is the dividend purification factor for Nanobiotix SA NBTX stock?

As of August 2026, the dividend purification factor for Nanobiotix SA (NBTX) is 98.92%. Purification (tazkiyah) is the practice of donating to charity the portion of dividend income attributable to incidental non-permissible sources, typically interest earned on a company's cash, and AAOIFI methodology requires it even for fully compliant stocks. The purification factor is the figure halal investors use to work out that donation on Nanobiotix SA dividends. It is recalculated with each monthly screening as new financial data arrives, and the Tabadulat app can help you calculate and track purification across your whole portfolio.

Does Nanobiotix SA NBTX pass the AAOIFI Preference Share screen?

Yes, as of August 2026, Nanobiotix SA stock (NBTX) passes the AAOIFI preference share screen. AAOIFI Shariah Standard No. 21 prohibits investing in preference shares because they grant holders guaranteed or priority rights to dividends and capital ahead of ordinary shareholders, a structure that conflicts with the Shariah principle that investors should share profit and loss in proportion to their ownership. Nanobiotix SA has no impermissible preference share structure affecting its ordinary shares, so the stock is compliant on this criterion. Like all AAOIFI screens, this is verified in each monthly review.

Invest Halal, Anytime, Anywhere

Download the Tabadulat app and start building your Shariah-compliant portfolio in minutes.

English

العربية

Nanobiotix SA

NASDAQ

Shariah-Compliant

Not Shariah

NBTX

About

Nanobiotix SA

NBTX

Nanobiotix S.A. is a pioneering biotechnology company focusing on developing innovative solutions for the treatment of cancer through nanomedicine. It primarily seeks to enhance the efficacy of existing radiotherapy methods, offering a higher precision level in targeting cancer cells while minimizing damage to surrounding healthy tissues. The spotlight of Nanobiotix's technological advancements is its proprietary NanoXray platform, designed to amplify the effects of radiation therapy, a cornerstone of cancer treatment. This platform holds significant promise in improving patient outcomes across various solid tumors, potentially re-defining standard care protocols. Operating through American Depositary Receipts (ADRs), Nanobiotix provides investors in the United States a convenient pathway to participate in its growth prospects. As an ADR, it underscores the global interest in innovative cancer treatment solutions, reflecting a broader trend of cross-border engagement in biotechnology. By pushing the frontiers of medical technology, Nanobiotix plays a critical role in the healthcare sector, illustrating how cutting-edge research can transform therapeutic landscapes and meet the pressing demands of oncological medicine.

Sector:

Healthcare

Industry:

Biotechnology

Employees:

108

Website:

https://www.nanobiotix.com

NBTX

Frequently asked questions

Related stocks

Mobile login screen for Tabadulat with fields to enter email, a Continue button, an option to create an account, and a language selector showing EN.

Step 1

Open your account.

Create your Tabadulat account in minutes: enter your details, complete identity verification, and add funds by secure transfer in multiple currencies. You're ready to start investing in halal stocks the same day.

Mobile screen showing add money interface with 100 AED amount and Manual Bank Transfer payment method selected, noting 1-2 business days processing.

Step 2

Deposit.

Add funds to your account using a secure payment method. You can deposit in multiple currencies to get started.

Step 3

Screen.

Screen Stocks for Free and explore a wide range of stocks that are ethically screened for Shariah compliance. Use our Halal Stock Screener to find the best opportunities.

Nanobiotix SA

About

Nanobiotix SA

NBTX

Frequently asked questions

Is Nanobiotix SA NBTX stock halal to invest in?

How often is Nanobiotix SA NBTX reviewed for Shariah compliance?

Does Nanobiotix SA NBTX pass the AAOIFI Non Permissible Income criteria?

Does Nanobiotix SA NBTX pass the AAOIFI Interest Bearing Investments criteria?

Does Nanobiotix SA NBTX pass the AAOIFI Interest Bearing Debt criteria?

What is the dividend purification factor for Nanobiotix SA NBTX stock?

Does Nanobiotix SA NBTX pass the AAOIFI Preference Share screen?

How do I buy Nanobiotix (NBTX) stock?

Open your account.

Deposit.

Screen.